•  
  •  
  •  
  •  

2023-10-01 01:07:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Kenvi Jewels Ltd to set up stall in Gujarat Gold Jewellery Show
  • SML ISUZU Ltd increases price of Trucks and Buses to cover increase in input cost
  • Bondada Engineering Ltd receives order worth Rs. 9.54 crore
  • Bandhan Bank is migrating its Core Banking System and Internet Banking to a new platform
  • TIPS Industries receives favourable judgment in dispute against Wynk

Keywords Selected:  FinalApproval

Stock Report

  • Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%
  • Caplin Steriles gets USFDA approval for Norepinephrine Bitartrate Injection
  • Zydus receives final approval from the USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day
  • Zydus receives final approval from the USFDA for Erythromycin Tablets USP, 250 mg and 500 mg
  • Zydus receives final approval from the USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg
  • Ajanta Pharma Ltd receives final approval from US FDA for Topiramate Extended Release Capsules
  • Zydus receives final approval from the USFDA for Zinc Sulfate Injection Pharmacy Bulk Package Vials
  • Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)
  • Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%
  • Eugia Pharma receives USFDA Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe
  • Eugia Pharma receives USFDA Approval for Vancomycin Hydrochloride for Injection USP, 1.25 g/vial and 1.5 g/vial, Single-Dose vials
  • Zydus receives Final Approval from the USFDA for Indomethacin Suppository with Competitive Generic Therapy designation
  • Aurobindo Pharma receives USFDA Approval for Saxagliptin Tablets, 2.5 mg and 5 mg
  • Glenmark Pharmaceuticals receives ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg
  • Zydus receives final approval from the USFDA for Plerixafor Injection USP, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial
  • Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial
  • Marksans announces FDA approval of OTC equivalent of Advil Dual Action Tablets
  • Zydus receives final approval from the USFDA for Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg
  • Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg
  • Zydus receives final approval from the USFDA for Diclofenac Sodium and Misoprostol Delayed Release Tablets
  • Zydus receives final approval from the USFDA for Varenicline Tablets
  • Caplin Steriles Ltd receives final approval from USFDA for ANDA Cisatracurium Besylate Injection USP
  • Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg
  • Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg

Latest Post

  • Kenvi Jewels Ltd to set up stall in Gujarat Gold Jewellery Show
  • SML ISUZU Ltd increases price of Trucks and Buses to cover increase in input cost
  • Bondada Engineering Ltd receives order worth Rs. 9.54 crore
  • Bandhan Bank is migrating its Core Banking System and Internet Banking to a new platform
  • TIPS Industries receives favourable judgment in dispute against Wynk


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2022